[Merkel Cell Carcinoma]

Area of Science:

• Oncology
• Dermatology
• Pathology

Context:

• Merkel cell carcinoma (MCC) is a rare but aggressive neuroendocrine skin cancer.
• Incidence is increasing, particularly in older populations (median age 75-80).
• Early metastasis is a characteristic feature of MCC.

Purpose:

• To highlight the evolving treatment landscape for Merkel cell carcinoma.
• To emphasize the growing importance of immunooncology in managing this aggressive tumor.
• To provide an overview of current therapeutic options.

Summary:

• Merkel cell carcinoma (MCC) is a rapidly growing neuroendocrine tumor with a propensity for early metastasis.
• Treatment modalities include surgery, radiotherapy, and chemotherapy.
• Immunooncology has emerged as a significant therapeutic strategy for MCC.

Impact:

• Increased awareness of MCC as a rising oncological concern in aging demographics.
• Highlights the critical role of immunooncology in improving outcomes for aggressive cancers.
• Informs clinical practice regarding multimodal treatment approaches for Merkel cell carcinoma.